Discover the latest breakthrough in STI treatment as zoliflodacin, a new antibiotic, shows effectiveness against drug-resistant gonorrhea in clinical trials.
Gonorrhea, the second most common STI in the U.S., has developed resistance to all antibiotics used to treat it, except for one last recommended therapy.
Gonorrhea, the second most common STI in the U.S., has developed resistance to all antibiotics used to treat it, except for one last recommended therapy.
Gonorrhea, the second most common STI in the U.S., has developed resistance to all antibiotics used to treat it, except for one last recommended therapy.